Glutamatergic input governs periodicity and synchronization of bursting activity in oxytocin neurons in hypothalamic organotypic cultures.
During suckling, oxytocin (OT) neurons display a bursting electrical activity, consisting of a brief burst of action potentials which is synchronized throughout the OT neuron population and which periodically occurs just before each milk ejection in the lactating rat. To investigate the basis of such synchronization, we performed simultaneous intracellular recordings from pairs of OT neurons identified retrospectively by intracellular fluorescent labelling and immunocytochemistry in organotypic slice cultures derived from postnatal rat hypothalamus. A spontaneous bursting activity was recorded in 65% of OT neurons; the remaining showed only a slow, irregular activity. Application of OT triggered bursts in nonbursting neurons and accelerated bursting activity in spontaneously bursting cells. These cultures included rare vasopressinergic neurons showing no bursting activity and no reaction to OT. Bursts occurred simultaneously in all pairs of bursting OT neurons but, as in vivo, there were differences in burst onset, amplitude and duration. Coordination of firing was not due to electrotonic coupling because depolarizing one neuron in a pair had no effect on the membrane potential of its partner and halothane and proprionate did not desynchronize activity. On the other hand, bursting activity was superimposed on volleys of excitatory postsynaptic potentials (EPSPs) which occurred simultaneously in pairs of neurons. EPSPs, and consequently action potentials, were reversibly blocked by the non-NMDA glutamatergic receptor antagonist CNQX. Taken together, these data, obtained from organotypic cultures, strongly suggest that a local hypothalamic network governs synchronization of bursting firing in OT neurons through synchronous afferent volleys of EPSPs originating from intrahypothalamic glutamatergic inputs.
Israel
Jean-Marc
JM
INSERM U 378, I.F.R. des Neurosciences, Université Victor Segalen Bordeaux 2, 1 rue Camille Saint-Saëns, F-33077 Bordeaux, France. jean-marc.Israel@bordeaux.inserm.fr
Le Masson
Gwendal
G
Theodosis
Dionysia T
DT
Poulain
Dominique A
DA
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000200:Action Potentials / Q000502:physiology*; D018685:Anesthetics, Inhalation / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001640:Bicuculline / Q000494:pharmacology; D001710:Biotin / Q000031:analogs & derivatives* / Q000378:metabolism; D002118:Calcium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004558:Electric Stimulation; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials; D018756:GABA Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000502:physiology*; D006221:Halothane / Q000494:pharmacology; D007031:Hypothalamus / Q000502:physiology*; D008239:Lysine / Q000031:analogs & derivatives* / Q000378:metabolism; D009474:Neurons / Q000502:physiology*; D009481:Neurophysins / Q000378:metabolism; D009924:Organ Culture Techniques; D010121:Oxytocin / Q000502:physiology*; D010507:Periodicity; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014667:Vasopressins / Q000378:metabolism
D018685:Anesthetics, Inhalation; D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D009481:Neurophysins; D011422:Propionates; C070614:neurobiotin; D014667:Vasopressins; D018698:Glutamic Acid; D010121:Oxytocin; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D001710:Biotin; C013411:biocytin; D008239:Lysine; D002118:Calcium; D006221:Halothane; D001640:Bicuculline